Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지

The Results of Postoperative Radiotherapy for Hypopharyngeal Carcinoma

하인두암 환자에서의 수술 후 방사선치료의 결과

  • Kim Won Taek (Departments of Radiation Oncology, Pusan National University) ;
  • Ki Yong Kan (Departments of Radiation Oncology, Pusan National University) ;
  • Nam Ji Ho (Departments of Radiation Oncology, Pusan National University) ;
  • Kim Dong Won (Departments of Radiation Oncology, Pusan National University) ;
  • Lee Byung Ju (Departments of Otolaryngology, Pusan National University) ;
  • Wang Su Gun (Departments of Otolaryngology, Pusan National University) ;
  • Kyuon Byung Hyun (Departments of Radiation Oncology, Pusan National University)
  • 김원택 (부산대학교 의과대학 방사선종양학교실) ;
  • 기용간 (부산대학교 의과대학 방사선종양학교실) ;
  • 남지호 (부산대학교 의과대학 방사선종양학교실) ;
  • 김동원 (부산대학교 의과대학 방사선종양학교실) ;
  • 이병주 (부산대학교 의과대학 이비인후과학교실) ;
  • 왕수건 (부산대학교 의과대학 이비인후과학교실) ;
  • 권병현 (부산대학교 의과대학 방사선종양학교실)
  • Published : 2004.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study was carried out to confirm clinical values and limitations of postoperative radiotherapy for hypopharyngeal carcinoma, to evaluate various prognostic factors which may affect to the treatment results and to use these results as fundamental data for making a new treatment strategy. Methods and Materials:. A retrospective analysis was peformed on 64 previously untreated patients with squamous cell carcinoma of the hypopharynx, seen between 1988 and 1999 at Pusan National University Hospital. Most of patients were treated by laryngopharyngectomy and neck dissection followed by conventional fractionated postoperative radiotherapy on surgical bed and cervical nodal areas. Results: The five-year overall survival rate and cause-specific survival rate were 42.2 percent and 51.6 percent, respectively. Univariate analysis of various clinical and pathologic factors confirmed the overall stage, TN-stage, secondary primary cancers, surgical positive margin, nodal extracapsular extension, total radiation doses as significant prognostic factors of hypopharyngeal carcinomas. But in multivariate analysis, TN-stage, surgical positive margin and extracapsular extesion were only statistically significant. Conclusion: In resectable cases of hypopharyngeal carcinoma, combined surgery and postoperative radio-therapy obtained good treatement results, even though sacrificing the function of larynx and pharynx. But in advanced and unresectable cases, with respect to survivals and qualify of life issues, we were able to confirm some limitations of combined therapy. So we recommend that comparative studies of recent various chemo-radiotherapy methods and advanced radiotherapy techniques with these data should be needed.

목적: 하인두암의 치료에서 수술 후 방사선치료에 대한 치료결과 분석을 통하여 그 임상적 의의와 한계를 알아보고, 방사선치료와 관련된 예후인자들을 확인하여 향후 새로운 치료방침을 세우는데 기본 자료를 마련하고자 연구를 시행하였다. 대상 및 방법: 1988년부터 1999년까지 부산대학교병원에서 원발성 하인두 편평상피세포암으로 진단되어 수술 후 방사선치료를 시행받은 64명을 대상으로 후향적 분석을 실시하였다. 모든 환자들은 근치적 목적의 종양절제술을 시행한 뒤에 통상적인 분할조사법을 이용하여 원발 부위와 경부 림프절 부위에 수술 후 방사선치료를 실시하였다. 결과: 5년간의 전체 생존율과 질병 관련 생존율은 각각 42.2%42.2%와 51.6%였고, 병기별 5년간 질병 관련 생존율은 Stage I, II, III, IV에서 각각 100%, 80%, 62.5%, 41.5%였다. 예후인자에 대한 단변랑 분석에서 전체 병기, T 병기 및 N 병기, 2차성 원발암 발생 유무, 절제연 침범 여부, 림프절의 외막 침범 여부, 총 방사선량 등이 의미가 있었으며, 다변량 분석에서는 T 병기 및 N 병기, 절제연 침범 여부, 림프절 외막 침범 여부 등이 유의한 예후인자로 판명 되었다. 결론: 절제 가능한 하인두암 환자에서 수술 및 보조적 방사선치료는 후두나 인두의 기능장애 가능성에도 불구하고 생존율이나 국소 제어율 면에서 좋은 치료 결과를 보였다 그러나 상당히 진행된 하인두암의 치료에서는 국소제어나 환자의 삶의 질과 관련하여 기존의 수술 및 방사선 병합치료의 한계를 확인할 수 있었는데, 최근 연구되고 있는 화학-방사선 병합요법이나 세기조절 방사선치료 등과의 비교 연구가 예후인자 관련 연구와 동반해서 진행되어야 할 것이다.

Keywords

References

  1. Pingree TF, Davis RK, Reichman O, et al. Treatment of hypopharyngeal carcinoma: a 10-year review of 1362 cases. Laryngoscope 1987;97:901-904
  2. Lefebvre JL. Larynx preservation: the discussion is not closed. Otolaryngol Head Neck Surg 1998;118:389-393 https://doi.org/10.1016/S0194-5998(98)70322-5
  3. Mendenhall WM, Parsons JT, Springer SP, et al. Squamous cell carcinoma of the head and neck treated with irradiation: Management of the neck. Semin Radiat Oncol 1992;2:163
  4. Kraus DH, Zelefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg 1997;116:637-641 https://doi.org/10.1016/S0194-5998(97)70240-7
  5. Keum KC, Lee CG, Kim GE, Lee KH. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal and hypopharyngeal cancer. J Korean Soc Ther Radiol 1993;13:277-284
  6. Sheldon JM, Zelefsky MJ. Hypopharyngeal cancer. In: Leibel SA, Phillips TL, eds. Textbook of radiation oncology. 1st ed. Philadelphia, W.B. Saunders Co. 1998:477-496
  7. Marks JE, Devineni VR, Harvey J, et al. The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx. Am J Otolaryngol 1992;13:34
  8. Garden AS, Morrison WH, Clayman GL, et al. Early squamous cell carcinoma of the hypophaynx: outcomes of treatment with radiation alone to the primary disease. Head Neck 1996;18:317-322 https://doi.org/10.1002/(SICI)1097-0347(199607/08)18:4<317::AID-HED2>3.0.CO;2-0
  9. Fein DA, Mendenhall WM, Parsons JT, et al. Pharyngeal wall carcinoma treated with radiotherapy: impact of treatment technique and fractionation. Int J Radiat Oncol Biol Phys 1993;26:751-757 https://doi.org/10.1016/0360-3016(93)90488-H
  10. Mendenhall WM, Million RR, Cassisi NJ. Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986;12:733
  11. Mendenhall WM, Parsons JT, Stringer SP, et al. Radiotherapy alone or combined with neck dissection for T1-2 carcinoma of the pyriform sinus: An alternative to consevative surgery. Int J Radiat Oncol Biol Phys 1993;27:1017
  12. Godballe C, Jorgensen K, Hansen O, et al. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. Laryngoscope 2002;112:834-838 https://doi.org/10.1097/00005537-200205000-00011
  13. Mendenhall WM, Parsons JT, Devine JW, et al. Squamous cell carcinoma of the pyriform sinus treated with surgery and/or radiotherapy. Head Neck Surg 1987;10:88-92 https://doi.org/10.1002/hed.2890100205
  14. Goepfert H, Lindberg RD, Jesse RH. Combined laryngeal conservation surgery and irradiation: Can we expand the indication for conservation therapy? Otolaryngol Head Neck Surg 1981;89:974
  15. Million RR. Carcinomas of the larynx and hypopharynx: Curative treatment with preservation of laryngeal function. Front Radiat Ther Oncol 1993;27:31
  16. Spector J, Sessions D, Emami B, et al. Squamous cell carcinomas of the aryepiglottic fold: therapeutic results and long-term follow up. Laryngoscope 1995;105:734-746 https://doi.org/10.1288/00005537-199507000-00012
  17. Slotman BJ, Kralendonk JH, Snow GB, et al. Surgery and postoperative radiotherapy and radiotherapy alone in T3-T4 cancers of the pyriform sinus. Treatment results and patterns of failure. Acta Oncol 1994;33:55-60 https://doi.org/10.3109/02841869409098376
  18. Frank JL, Garb JL, Kay S, et al. Postoperative radiotherapy improve survival in squamous cell carcinoma of the hypopharynx. Am J Surg 1994;168:476-480 https://doi.org/10.1016/S0002-9610(05)80105-9
  19. Bahadur S, Thakar A, Mohanti BK, et al. Results of radiotherapy with, or without, salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of the hypopharynx. J Laryngol Otol 2002;116:29-32
  20. Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev 1975;2:177-191 https://doi.org/10.1016/S0305-7372(75)80002-8
  21. Tupchong L, Scott CB, Blitzer PH, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck cancer: Long-term follow-up of RTOG study 73-03. Int J Radit Oncol Biol Phys 1991;20:21
  22. Bataini P, Brugere J, Berniere J. Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus. Int J Radiat Oncol Biol Phys 1982;8:1277
  23. Dubois J, Guerrier B, Di Ruggiero J, et al. Cancer of the pyriform sinus: treatment by radiation therapy alone and after surgery. Radiology 1986;160:831-836 https://doi.org/10.1148/radiology.160.3.3737924
  24. Schuller DE, Stein DW, Metch B. Analysis of treatment failure patterns. A Southwest Oncololgy Group Study. Arch Otolaryngol Head Neck Surg 1989;115:834
  25. Jacobs C, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol 1990;8:838
  26. Laramore GE, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:705
  27. Zelefsky MJ, Kraus DH, Pfister DG, et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 1996;18:405-411 https://doi.org/10.1002/(SICI)1097-0347(199609/10)18:5<405::AID-HED3>3.0.CO;2-9
  28. Kim S, Wu HG, Heo DS, et al. Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head Neck 2001;23:713-717 https://doi.org/10.1002/hed.1101
  29. Pfreundner L, Hoppe F, Willner J, et al. Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas-a possibility for organ preservation. Radiother Oncol 2003;68:163-170 https://doi.org/10.1016/S0167-8140(03)00076-8
  30. Adelstein DJ, Saxton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997;19:567-575 https://doi.org/10.1002/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.0.CO;2-5
  31. Samant S, Kumar P, Wan J, et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 1999;21:595-601 https://doi.org/10.1002/(SICI)1097-0347(199910)21:7<595::AID-HED2>3.0.CO;2-J
  32. Schuller ED, Grecula JC, Agrawal A, et al. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx. Cancer 2002;94:3169-3178 https://doi.org/10.1002/cncr.10571
  33. Harrison LB, Pfister DG, Fass DE, et al. Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 1991;21:703
  34. Garden AS, Morrison WH, Ang KK, et al. Hyperfractionated radiation in the treatment of squamous cell carcinoma as of the head and neck: a comparison of two fractionation schedules. Int J Radiat Oncol Biol Phys 1995;31:493-502 https://doi.org/10.1016/0360-3016(94)00334-H
  35. Chao KSC, Wippold F, Ozyigit G, et al. Determination and delineation of nodal target volumes for head and neck cancer based on the patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002;53:1174-1184 https://doi.org/10.1016/S0360-3016(02)02881-X
  36. Chao KSC, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: Impact of tumor volume. Int J Radiat Oncol Biol Phys 2004;59:43-50 https://doi.org/10.1016/j.ijrobp.2003.08.004
  37. Hinerman RW, Amdur RJ, Mendenhall WM, et al. Hypopharyngeal carcinoma. Curr Treat Options Oncol 2002;3:41-49 https://doi.org/10.1007/s11864-002-0040-1
  38. Pfreundner L, Willner J, Marx A, et al. The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 2000; 47:1287-1297 https://doi.org/10.1016/S0360-3016(00)00514-9
  39. Ozyigit G, Chao K. Hypopharynx. In: Chao K, Ozyigit G. Intensity modulated radiation therapy for head & neck cancer. 1st ed. Philadelphia, Lippincott Williams & Wilkins. 2003:127-138
  40. Vandenbrouck C, Eschwege F, De la Rochefordiere A, et al. Squamous cell carcinoma of the pyriform sinus: retrospective study of 351 cases treated at the Institut Gustave-Roussy. Head Neck Surg 1987;10:4-13 https://doi.org/10.1002/hed.2890100103
  41. Richard J, Sancho-Garnier H, Saravane D, et al. Prognostic factors in cervical lymph node metastasis in upper respiratory and digestive tract carcinomas: study of 1713 cases during a 15-year period. Laryngoscope 1987;97:97-101
  42. Brasilino de Carvalho M. Quantative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 1998;20:16-21 https://doi.org/10.1002/(SICI)1097-0347(199801)20:1<16::AID-HED3>3.0.CO;2-6
  43. Emami B, Spector J. Hypopharynx. In: Brady L, ed. Principles and practice of radiation oncology. 3rd ed. Philadelphia: Lippincott-Raven, 1998:1047-1068
  44. Bastit L, Blot E, Debourdeau P, et al. Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2001;49:139-146 https://doi.org/10.1016/S0360-3016(00)01376-6
  45. Barzan L, Talamini R, Politi D, et al. Squamous cell carcinoma of the hypopharynx treated with surgery and radiotherapy. J Laryngol Otol 2002;116:24-28
  46. Bradley J, Thorstad WL, Mutic S, et al. Impact of FDGPET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003;59:78-86